查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2105695

全球淋巴水腫治療市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Lymphedema Treatment Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 206 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球淋巴水腫治療市場預計將從2025年的91.9億美元成長至2034年的191.2億美元，2026年至2034年的複合年成長率（CAGR）為8.48%。該市場正穩步成長，這得益於全球對淋巴疾病的認知不斷提高以及專業醫療服務的持續改善。淋巴水腫的治療方法包括壓迫療法、物理治療、手術干預、藥物治療以及旨在減輕腫脹和改善患者活動能力的先進醫療設備。癌症相關性淋巴水腫發生率的上升、人口老化以及醫療保健成本的不斷增加是推動市場擴張的主要因素。對早期診斷的日益重視也促進了對有效治療方案的需求。

醫療專業人員正在採用創新壓力衣、氣動加壓裝置和微創手術來改善治療效果。復健技術、影像技術和病患監測技術的進步正在改善疾病管理和患者的生活品質。針對淋巴系統疾病和再生醫學的研究活動活性化，為產品開發創造了機會。專業治療中心的擴張進一步推動了市場成長。

憑藉著個人化的治療方案和持續的醫療創新，前景依然光明。數位健康平台、穿戴式監測設備和改進的復健計畫將提升患者照護。新興經濟體醫療保健投資的增加以及人們對慢性淋巴疾病認知的不斷提高，將支持持續的需求。技術的不斷進步和臨床研究的不斷深入，將進一步推動全球淋巴水腫治療的改善。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球淋巴水腫治療市場：按類型分類

  • 市場分析、洞察與預測
  • 續發性淋巴水腫
  • 原發性淋巴水腫

第5章：全球淋巴水腫治療市場：依治療類型分類

  • 市場分析、洞察與預測
  • 保守/非侵入性療法
  • 醫療器材
  • 手術介入
  • 藥物治療

第6章：全球淋巴水腫治療市場：依受累部位分類

  • 市場分析、洞察與預測
  • 上肢淋巴水腫
  • 下肢淋巴水腫
  • 頭頸部淋巴水腫
  • 生殖器和軀幹淋巴水腫

第7章 全球淋巴水腫治療市場：依最終使用者分類

  • 市場分析、洞察與預測
  • 醫院
  • 淋巴水腫治療中心和復健診所
  • 門診手術中心（ASC）
  • 居家醫療

第8章 全球淋巴水腫治療市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第9章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第10章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Tactile Medical
    • Medi GmbH
    • SIGVARIS GROUP
    • Bio Compression Systems
    • AIROS Medical
    • L&R Group
    • Huntleigh Healthcare（Getinge）
    • Koya Medical
    • Solventum
    • Juzo
    • JOBST（Essity）
    • ImpediMed Limited
    • Lympha Press（Mego Afek）
簡介目錄
Product Code: VMR112119261

The global lymphedema treatment market size is expected to reach USD 19.12 Billion in 2034 from USD 9.19 Billion in 2025, growing at a CAGR of 8.48 during 2026-2034.This market is experiencing consistent growth as awareness of lymphatic disorders and access to specialized healthcare services continue improving worldwide. Lymphedema treatment includes compression therapy, physiotherapy, surgical interventions, pharmaceuticals, and advanced medical devices designed to reduce swelling and improve patient mobility. Rising incidence of cancer-related lymphedema, expanding aging populations, and increasing healthcare expenditure are contributing significantly to market expansion. Growing emphasis on early diagnosis is also supporting demand for effective treatment solutions.

Healthcare providers are adopting innovative compression garments, pneumatic compression devices, and minimally invasive surgical procedures to improve treatment outcomes. Advances in rehabilitation techniques, diagnostic imaging, and patient monitoring technologies are enhancing disease management and quality of life. Increasing research activities focused on lymphatic disorders and regenerative medicine are creating favorable opportunities for product development. Expansion of specialized treatment centers is further strengthening market growth.

The future outlook remains promising as personalized treatment approaches and medical innovation continue advancing. Digital health platforms, wearable monitoring devices, and improved rehabilitation programs will enhance long-term patient care. Growing healthcare investments in emerging economies and increasing awareness of chronic lymphatic disorders will support sustained demand. Continuous technological progress and clinical research will drive further improvements in lymphedema management worldwide.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

  • Secondary Lymphedema
  • Primary Lymphedema

By Treatment Type

  • Conservative/Non-Invasive Therapy
  • Medical Devices
  • Surgical Interventions
  • Pharmacological Therapy

By Affected Area

  • Upper Extremity Lymphedema
  • Lower Extremity Lymphedema
  • Head & Neck Lymphedema
  • Genital & Truncal Lymphedema

By End User

  • Hospitals
  • Lymphedema Treatment Centers & Rehabilitation Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Home Care Settings

COMPANIES PROFILED

  • Tactile Medical, medi GmbH, SIGVARIS GROUP, Bio Compression Systems, AIROS Medical, L&R Group, Huntleigh Healthcare (Getinge), Koya Medical, Solventum, Juzo, JOBST (Essity), ImpediMed Limited, Lympha Press (Mego Afek)

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL LYMPHEDEMA TREATMENT MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Secondary Lymphedema Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Primary Lymphedema Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL LYMPHEDEMA TREATMENT MARKET: BY TREATMENT TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Treatment Type
  • 5.2. Conservative/Non-Invasive Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Medical Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Surgical Interventions Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Pharmacological Therapy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL LYMPHEDEMA TREATMENT MARKET: BY AFFECTED AREA 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Affected Area
  • 6.2. Upper Extremity Lymphedema Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Lower Extremity Lymphedema Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Head & Neck Lymphedema Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Genital & Truncal Lymphedema Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL LYMPHEDEMA TREATMENT MARKET: BY END USER 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast End User
  • 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Lymphedema Treatment Centers & Rehabilitation Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Ambulatory Surgical Centers (ASCs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Home Care Settings Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL LYMPHEDEMA TREATMENT MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By Type
    • 8.2.2 By Treatment Type
    • 8.2.3 By Affected Area
    • 8.2.4 By End User
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By Type
    • 8.3.2 By Treatment Type
    • 8.3.3 By Affected Area
    • 8.3.4 By End User
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By Type
    • 8.4.2 By Treatment Type
    • 8.4.3 By Affected Area
    • 8.4.4 By End User
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By Type
    • 8.5.2 By Treatment Type
    • 8.5.3 By Affected Area
    • 8.5.4 By End User
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By Type
    • 8.6.2 By Treatment Type
    • 8.6.3 By Affected Area
    • 8.6.4 By End User
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL LYMPHEDEMA TREATMENT INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Tactile Medical
    • 10.2.2 Medi GmbH
    • 10.2.3 SIGVARIS GROUP
    • 10.2.4 Bio Compression Systems
    • 10.2.5 AIROS Medical
    • 10.2.6 L&R Group
    • 10.2.7 Huntleigh Healthcare (Getinge)
    • 10.2.8 Koya Medical
    • 10.2.9 Solventum
    • 10.2.10 Juzo
    • 10.2.11 JOBST (Essity)
    • 10.2.12 ImpediMed Limited
    • 10.2.13 Lympha Press (Mego Afek)